DK3157577T3 - Automatisk procesplatform til fremstilling af astatin-211 [at-211]-radiofarmaka - Google Patents

Automatisk procesplatform til fremstilling af astatin-211 [at-211]-radiofarmaka Download PDF

Info

Publication number
DK3157577T3
DK3157577T3 DK15809093.6T DK15809093T DK3157577T3 DK 3157577 T3 DK3157577 T3 DK 3157577T3 DK 15809093 T DK15809093 T DK 15809093T DK 3157577 T3 DK3157577 T3 DK 3157577T3
Authority
DK
Denmark
Prior art keywords
astatin
manufacture
automatic process
process platform
pharmacy
Prior art date
Application number
DK15809093.6T
Other languages
English (en)
Inventor
Sture Lindegren
Emma Aneheim
Original Assignee
Alpha Therapy Solutions Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapy Solutions Ab filed Critical Alpha Therapy Solutions Ab
Application granted granted Critical
Publication of DK3157577T3 publication Critical patent/DK3157577T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008Peptides; Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1051Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • G21G2001/0094Other isotopes not provided for in the groups listed above

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK15809093.6T 2014-06-18 2015-06-17 Automatisk procesplatform til fremstilling af astatin-211 [at-211]-radiofarmaka DK3157577T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462013678P 2014-06-18 2014-06-18
PCT/SE2015/050714 WO2015195042A1 (en) 2014-06-18 2015-06-17 AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS

Publications (1)

Publication Number Publication Date
DK3157577T3 true DK3157577T3 (da) 2021-01-18

Family

ID=54935878

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15809093.6T DK3157577T3 (da) 2014-06-18 2015-06-17 Automatisk procesplatform til fremstilling af astatin-211 [at-211]-radiofarmaka

Country Status (8)

Country Link
US (2) US10829423B2 (da)
EP (1) EP3157577B8 (da)
JP (1) JP6830435B2 (da)
CN (1) CN107073141B (da)
DK (1) DK3157577T3 (da)
ES (1) ES2843625T3 (da)
PL (1) PL3157577T3 (da)
WO (1) WO2015195042A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2552151A (en) * 2016-07-08 2018-01-17 Univ Oslo Cyclotron target
CN111465577B (zh) 2017-12-07 2023-07-28 国立大学法人大阪大学 砹的制造方法
EP3733216A4 (en) * 2017-12-29 2021-08-11 Osaka University ASTATE SOLUTION AND ITS PRODUCTION PROCESS
US20210210244A1 (en) * 2018-03-15 2021-07-08 Osaka University Radionuclide preparation system, storage medium readable by computer storing radionuclide preparation program, radionuclide preparation method, and terminal device
US11776705B1 (en) * 2020-01-16 2023-10-03 Innosense Llc High temperature and high beam current compatible targets and methods thereof for generating noble gas/radiohalogen generators for medical isotopes
CN114249301B (zh) * 2021-11-10 2023-06-16 砹尔法纽克莱(宁波)医疗科技有限公司 一种洗脱溶液及用于靶向核素药的放射性核素砹-211的制备方法
CN118678997A (zh) * 2021-12-14 2024-09-20 德克萨斯A&M大学系统 自动分离和回收砹的系统和方法
WO2024094882A1 (en) 2022-11-05 2024-05-10 Atley Solutions Ab Automatic scraper for radioactive substances

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681727A (en) * 1984-04-10 1987-07-21 The United States Of America As Represented By The United States Department Of Energy Process for producing astatine-211 for radiopharmaceutical use
EP0203764B1 (en) 1985-05-17 1993-03-24 Neorx Corporation Radiohalogenated small molecules for protein labeling
US4826672A (en) 1985-06-07 1989-05-02 President And Fellows Of Harvard College Astatinated organic compounds
US5102651A (en) 1989-12-29 1992-04-07 Neorx Corporation Process for isolation and radiolabeling of pharmaceuticals with isotopes of astatine
DE4239344A1 (en) * 1991-12-20 1993-06-24 Sulzer Ag Robotic machining of workpieces using scraping process - involves manipulating workpiece so that features to be machined are drawn past scraper blade under controlled pressure
NO314537B1 (no) 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
US6749830B2 (en) * 2001-01-31 2004-06-15 Centre For Addiction And Mental Health Method for the synthesis of radiolabeled compounds
WO2003064678A2 (en) 2002-01-31 2003-08-07 Bioscan, Inc. Apparatus for synthesis of radiolabeled compounds
DE602004015454D1 (de) 2003-06-25 2008-09-11 Peregrine Pharmaceuticals Inc Verfahren und vorrichtung zur kontinuierlichen radioaktiven markierung von proteinen im grossen massstab
AU2003904201A0 (en) 2003-08-11 2003-08-21 Allen, Barry John Mr Alpha-conjugate of C595 for therapy of pancreatic, prostate and other cancers
US8337810B2 (en) 2005-12-22 2012-12-25 Duke University Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
WO2010021719A1 (en) 2008-08-19 2010-02-25 The Regents Of The University Of California Modular radiochemistry synthesis system
US8435454B2 (en) * 2009-07-09 2013-05-07 Siemens Medical Solutions Usa, Inc. Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure
US8273300B2 (en) 2009-07-09 2012-09-25 Siemens Medical Solutions Usa, Inc. Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure

Also Published As

Publication number Publication date
PL3157577T3 (pl) 2021-04-19
CN107073141B (zh) 2021-06-29
CN107073141A (zh) 2017-08-18
US10829423B2 (en) 2020-11-10
EP3157577A4 (en) 2018-03-07
EP3157577B8 (en) 2020-12-23
EP3157577B1 (en) 2020-10-28
US20210139389A1 (en) 2021-05-13
WO2015195042A1 (en) 2015-12-23
JP2017528512A (ja) 2017-09-28
JP6830435B2 (ja) 2021-02-17
US11851383B2 (en) 2023-12-26
EP3157577A1 (en) 2017-04-26
ES2843625T3 (es) 2021-07-19
US20180215680A1 (en) 2018-08-02

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3473783T3 (da) Fremgangsmåde til fremstilling af gulvplader
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3157577T3 (da) Automatisk procesplatform til fremstilling af astatin-211 [at-211]-radiofarmaka
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK2966044T3 (da) Fremgangsmåde til fremstilling af skumglas
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
DK3166904T3 (da) Fremgangsmåde til fremstilling af betonelementer
DK3174988T3 (da) Fremgangsmåde til fremstilling af mælkesyre
DK3359522T3 (da) Proces til fremstilling af N-Boc-bifenylalaninol
DK3166927T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxy-picolinsyre
DK3201346T3 (da) Fremgangsmåder til fremstilling af biopolymer-matrix kompositmaterialer
DK3218396T3 (da) Fremgangsmåde til fremstilling af højaffinitets antistoffer
DK3262023T3 (da) Fremgangsmåde til fremstillingen af diener
DK3250523T3 (da) Fremgangsmåde til fremstillingen af en silikasmeltemasse
DK3274143T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3175571T3 (da) Fremgangsmåder til tilpasning af over-the-air-synkronisering til radioforhold
DK3166923T3 (da) Fremgangsmåde til fremstilling af substituerede phenylalkaner
DK3286209T3 (da) Fremgangsmåde til fremstilling af gonadotrophin
DK3386947T3 (da) Fremgangsmåde til fremstilling af n-retinoylaminoalkansulfonsyre
DK3256460T3 (da) Fremgangsmåde til fremstilling af lactid
DK3253743T3 (da) Syntetisk fremgangsmåde til fremstilling af 2-furansyre-derivater
DK3172757T3 (da) Fremgangsmåde til automatisk korrektion af astigmastisme